S&P/ASX 200 Index (ASX: XJO) shares are 0.3% higher at 9,086.1 points on Monday.
Let's start the new week with some fresh ratings from the experts
The CSL share price is $170.37, up 1.3% today and down 21% over 12 months.
CSL shares soared 23% last week after the company released its FY26 results and provided a positive outlook.
The CSL share price has ripped 85% since the healthcare sector began its long-awaited rebound on 3 June.
Morgans has a buy rating on this ASX 200 healthcare giant.
Analyst Derek Jellinek said:
The FY26 result was broadly in line with expectations, with revenue of US$15.8bn (+3% vs guidance) and underlying NPATA of US$3.1bn.
Importantly, underlying Ig demand remains strong, Seqirus delivered seasonal influenza growth despite lower US immunisation rates and transformation savings reached US$176m ahead of target, although Vifor continues to face challenges.
While FY27 targets flat top line growth, as Vifor remains a significant drag, the earnings trajectory is becoming increasingly skewed towards recovery, supported by stabilising plasma economics, cost-outs and improved commercial execution.
We make modest changes to FY27-28 estimates and increase our blended DCF, PE and EV/EBITDA-based target price to A$187.71 on a multiple roll forward.
The BHP share price hit a new record high of $67.72, up 3.9%, in early trading on Monday.
BHP released its FY26 report last week, and following this, John Athanasiou from Red Leaf Securities gave the miner a hold rating.
Athanasiou said (courtesy The Bull):
The company posted attributable profit of $US9.8 billion in full year 2026, up 9 per cent on the prior corresponding period. Revenue of $US58.8 billion was up 15 per cent.
The company's copper portfolio is positioned to benefit from electrification, renewable infrastructure, power grid investment and data centre growth.
However, BHP remains heavily exposed to iron ore, leaving earnings sensitive to Chinese demand and commodity price movements.
The quality of BHP's asset base, balance sheet and diversified portfolio leaves existing shareholders with little reason to sell.
However, after a solid run, prospective investors may be better served waiting for a potentially more attractive entry point.
The Westpac share price is $33.60, down 0.7% today and down 12% over 12 months.
Following Westpac's 3Q FY26 update, Athanasiou put a sell rating on the ASX 200 bank share.
He said:
The bank remains well capitalised and continues to generate solid earnings, but the operating environment is becoming increasingly competitive.
Mortgage pricing is aggressive, deposit competition remains intense and the scope for sustained margin expansion appears limited.
Westpac's dividend remains attractive, but investors should also consider opportunity cost.
We believe there are more compelling opportunities on the ASX, which offer stronger structural growth or more attractive valuations.
The post Buy, hold, sell: CSL, BHP, Westpac shares appeared first on The Motley Fool Australia.
Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended BHP Group and CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2026